CASºÅ²éѯ»¯¹¤²úÆ·

ÈÈÃÅËÑË÷»¯Ñ§Æ·×î¶àÖ»ÏÔʾǰ20Ìõ£¬Çëµã»÷¡°ËÑË÷»¯Ñ§Æ·¡±²é¿´ËùÓнá¹û


CASµÇ¼ºÅ ÖÐÎÄÃû Ó¢ÎÄÃû ·Ö×ӽṹʽ ·Ö×Óʽ ÏêÇé ¹©Ó¦ÉÌ
444731-52-6ÅÁßòÅÁÄá;
5-[[4-[(2,3-¶þ¼×»ù-2H-ßÅßò-6-»ù)(¼×»ù)°±»ù]à×à¤-2-»ù]°±»ù]-2-¼×»ù±½»Çõ£°·
Pazopanib;
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;
GW 786034;
Benzenesulfonamide,5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-;
Votrient;
CAS:444731-52-6·Ö×ӽṹC21H23N7O2SÏêÇ鹩ӦÉÌ
444731-75-3N-(2-ÂÈà×à¤-4-»ù)-N-¼×»ù-2,3-¶þ¼×»ù-2H-ßÅßò-6-°·2H-Indazol-6-amine,N-(2-chloro-4-pyrimidinyl)-N,2,3-trimethyl-;
N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine
CAS:444731-75-3·Ö×ӽṹC14H14ClN5ÏêÇ鹩ӦÉÌ
444731-74-2N-(2-ÂÈà×à¤-4-»ù)- 2,3-¶þ¼×»ù-2H-ßÅßò-6-°·2H-Indazol-6-amine,N-(2-chloro-4-pyrimidinyl)-2,3-dimethyl-;
N-(2-Chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine
CAS:444731-74-2·Ö×ӽṹC13H12ClN5ÏêÇ鹩ӦÉÌ
221681-94-32,3-¶þ¼×»ù-2H-ßÅßò-5-°·2,3-Dimethyl-2H-indazol-5-amineÎÞÏêÇ鹩ӦÉÌ
1783625-55-72,3-¶þ¼×»ù-2H-ßÅßò-7-°·2,3-Dimethyl-2H-indazol-7-amineÎÞÏêÇ鹩ӦÉÌ
1782433-66-22,3-¶þ¼×»ù-2H-ßÅßò-4-°·2,3-Dimethyl-2H-indazol-4-amineÎÞÏêÇ鹩ӦÉÌ
ÈÈÃÅËѹؼü´Ê:C9H12Cl2 GAMMA AMINOBUTYRIC ACID C10 H20 O2 C15H30N2O3 CH3 OH Ethanylylidene pane [Rh©vCOD©wCl]2 ALKYL GLYCIDYL ETHER ADPM 2,3-»·Ñõ±û»ù¶¡ÃÑ Deuterium Fluoride °±»ù ¹è C4 H6 O C9H17O6N TACK HC2H3O2 * 2-°±»ù-3,4-¶þ¼×»ù gluca ßÕຠϩ Hina EC 321€ Bek4n5 Dipyridamole 1h È«·ú Íé Ö¬ ·¾ °· C10H9NS2 35373-06-9 C11H11NO5S cashew C10H10NO4 C12H22O11¡¤H2O ·Ó °· Ó²Ö¬õ£ ÂÈ N-?e D-ÆÏÌÑÌÇËáÄÆÑΠmoss 4,4'-¶þ°±»ù-2,2'-Ë«Èý·ú¼×»ùÁª±½ »ù±ûÏ©´¼ butyroxy Áª±½ Ñõ